by Sue Robbins | Nov 2, 2020 | Migraine
Treatment with fremanezumab, the fully humanized IgG2?a monoclonal antibody that selectively targets calcitonin gene-related peptide, significantly reduced the number of headache or migraine days experienced before therapy. These findings, from a pooled analysis of...
by Sue Robbins | Aug 20, 2020 | Migraine
Predictors of chronic migraine Recent data from a systematic review and meta-analysis point to clinical and sociodemographic factors associated with migraine chronification INTERNATIONAL HEADACHE SOCIETY London, UK: A meta-analysis published in the...
by Sue Robbins | Aug 13, 2020 | Migraine
I was sitting in my neurologist’s office, as my doctor and I reviewed the long list of things we’d already tried to treat my chronic migraine—supplements and hard-to-pronounce drugs, abortive and preventative medications, near-misses and...
by Sue Robbins | Jul 15, 2020 | Migraine
Compared with healthy control participants, pediatric patients with chronic migraine (CM) report a higher rate of depression, according to study findings published in Pediatric Neurology. Researchers suggested that clinicians should consider including therapy in...
by Sue Robbins | Feb 7, 2020 | Miscellaneous
Craniosacral therapy (CST) may have major therapeutic benefits to those suffering from chronic pain, a new literature review published in BMC Musculoskeletal Disorders found. The literature review examined randomized controlled trials for craniosacral therapy (CST) in...